Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Evelo Biosciences, Inc. (EVLO) had Return on Equity of 46.29% for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-12.36M |
|
-- |
|
-- |
|
$11.18M |
|
$-11.18M |
|
$-1.20M |
|
$-12.38M |
|
$-12.38M |
|
$-12.36M |
|
$-12.36M |
|
$-12.36M |
|
$-12.36M |
|
$-11.18M |
|
$-11.01M |
|
17.38M |
|
17.38M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$18.94M |
|
$0.89M |
|
$1.69M |
|
$20.63M |
|
$39.76M |
|
-- |
|
$7.57M |
|
$47.33M |
|
$-26.71M |
|
$-26.71M |
|
$-26.71M |
|
18.85M |
|
| Cash Flow Statement Financials | |
$-50.51M |
|
$0.50M |
|
$19.02M |
|
$49.10M |
|
$18.06M |
|
$-31.04M |
|
$7.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.48 |
|
-- |
|
-- |
|
-- |
|
-1.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-50.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
46.29% |
46.30% |
|
-59.94% |
|
46.30% |
|
$-1.42 |
|
$-2.88 |
|
$-2.91 |
|